FDA Brief

Warning letters Food

FDA warning letter to

Dr. Thomas Polucki Upper Cervical Chiropractic, Inc.

High riskIssued Jul 28, 2021Posted Aug 4, 2021Center for Food Safety and Applied Nutrition

Dr. Thomas Polucki Upper Cervical Chiropractic sold Nitric Oxide Support and Melatonin with website claims to treat or prevent COVID-19, FDA says.

What happened

FDA and FTC reviewed https://getbetterxshop.com in June 2021 (FDA June 2; FTC June 9) and found Nitric Oxide Support and Melatonin offered for sale with claims to mitigate, prevent, treat, diagnose, or cure COVID-19. FDA says these are unapproved new drugs and misbranded drugs. FTC also reviewed https://santaclaritachiropractor.com and cited claims that upper cervical chiropractic care and supplements provided an immune boost against COVID-19.

What FDA found

  1. FDA says Nitric Oxide Support and Melatonin are unapproved new drugs because the company sells them with claims to mitigate, prevent, treat, diagnose, or cure COVID-19 without FDA approval.

    section 505(a) of the FD&C Act, 21 U.S.C. § 355(a)
  2. FDA says the products are misbranded drugs, meaning their labeling or promotion is improper under the law.

    section 502 of the FD&C Act, 21 U.S.C. § 352
  3. FDA says putting these products into interstate commerce is prohibited.

    sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d)
  4. FDA cites website text and tags, including “coronavirus” and “COVID19,” that present the products as safe or effective for COVID-19.

    sections 505(a) and 502 of the FD&C Act, 21 U.S.C. § 355(a) and § 352
  5. FTC says the company made COVID-19 prevention and treatment claims without competent and reliable scientific evidence, including claims about chiropractic care and supplements.

    FTC Act, 15 U.S.C. 41 et seq.

What FDA wants

FDA tells the company to take immediate action to stop selling any unapproved and unauthorized products for COVID-19, review its websites and promotional materials, and email COVID-19-Task-Force-CFSAN@fda.hhs.gov within 48 hours with the specific steps taken and steps to prevent recurrence. If it cannot act within 48 hours, FDA asks it to state why and when it will.

Who should pay attention

  • dietary supplement sellers making COVID-19 or immune claims
  • chiropractic and functional medicine clinics with health claim websites
  • e-commerce stores that tag products with disease names

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Medolife Rx D/B/A MedoLife Corp., AELIA, Inc. and Quanta Inc.

    FDA says Medolife sold unapproved Escozine drugs online with claims to treat cancer, HIV, and COVID-19.

    High risk
  2. www.ivermectin4covid.com

    FDA warned website ivermectin4covid.com for selling unapproved, misbranded ivermectin drugs claiming COVID-19 use.

    High risk
  3. Medical Mikes, Inc.

    FDA and FTC warned Medical Mikes over unapproved CBD claims to prevent or treat COVID-19.

    High risk
  4. Purecraft LLC

    FDA and FTC warn Purecraft LLC over CBD products marketed with unapproved COVID-19 prevention and treatment claims.

    High risk